Raia Drogasil S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
March 04, 2024
Share
Raia Drogasil S.A. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was BRL 9,557.39 million compared to BRL 8,351.13 million a year ago. Revenue was BRL 8,924.32 million compared to BRL 7,836.25 million a year ago. Net income was BRL 283.32 million compared to BRL 301.1 million a year ago.
For the full year, the company reported sales was BRL 33,973.79 million compared to BRL 29,067.38 million a year ago. Net income was BRL 1,054.97 million compared to BRL 996.11 million a year ago. Basic earnings per share from continuing operations was BRL 0.62233 compared to BRL 0.5813 a year ago.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
RAIA DROGASIL S.A. 
